Omni Family Health
Analysis
Omni Family Health is a registered charity in United States, based in Bakersfield, CA. It received its IRS tax-exemption ruling in March 1987, 39 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a hospital or medical research organisation under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending March 2023, Omni Family Health reported income of $139.0m and spending of $134.2m, spending 97% of its income. Across the 5 years on record, from March 2019 to March 2023, income grew from $100.0m to $139.0m (+39%), an average of +8.6% a year. The sharpest change came in the year to March 2020, when income rose by 16%. Over the whole period it spent 96% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Omni Family Health sits at the 96th percentile: it is larger than about 96% of them. Against every charity in United States with reported income it ranks in the 99th percentile, and in the 100th percentile within CA. Charities of a similar size with the same main cause include JWCH Institute Inc ($138.6m), Solutionhealth ($139.5m) and Avera Marshall ($138.6m).
On its Form 990 for the period ending March 2023, revenue came from contributions and grants 17% and program service revenue 79% of the total. Compensation of current officers, directors and key employees was $2.5m (1.8% of expenses). Other salaries and wages came to $57.9m. At year end it held assets of $163.6m against liabilities of $95.2m, net assets of $68.4m. It reported 1,125 employees.
Income and spending
Where the income comes from
- Contributions & grants 17%
- Program services 79%
- Other 4.1%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| JWCH Institute Inc | Commerce | $138.6m |
| Solutionhealth | Manchester | $139.5m |
| Avera Marshall | Marshall | $138.6m |
| Mary Rutan Hospital | Bellefontaine | $139.6m |